STING1 and neoplasm: Currently, the STING signalling pathway is over-activated in tumours with low antigenicity, tumours that release a significant amount of DNA from the cytoplasm due to exposure to potent carcinogens, and tumours with chromosomal instability (CIN) phenotype, which might promote tumour growth and metastasis.